ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

37,320Medicare Part D Prescriptions Filled, Including Refills

Rank: 7 out of 2888

$2.62M Total Retail Price of All Prescriptions

Rank: 11 out of 2888

842 Patients Receiving at Least One Drug in Part D
54%Patients 65 Years and Older
95% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Texas
Lower avg

Schedule Two
Controlled Substances

2% of this provider’s 842 patients filled at least one prescription for a schedule two drug, compared to an average of 1%.

Schedule Three
Controlled Substances

14% of this provider’s 842 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

2% of this provider’s 20,682 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 27%.

Prescription Price

$70 was the average price of a prescription from this provider, compared to $67 among peers.

Prescriptions per Patient

44 is the average number of prescriptions (including refills) per patient, compared to an average of 19.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Texas
SIMVASTATIN 1,651 663 1 2
LEVOTHYROXINE SODIUM 1,267 506 2 1
RISPERIDONE 904 470 3 72
LISINOPRIL 794 607 4 3
FUROSEMIDE 723 578 5 6
METOPROLOL TARTRATE 672 505 6 10
MIRTAZAPINE 592 464 7 54
TRAMADOL HCL 568 502 8 16
NAMENDA 549 501 9 34
TRAZODONE HCL 545 280 10 43
ATORVASTATIN CALCIUM 534 244 11 9
AMLODIPINE BESYLATE 528 337 12 5
DONEPEZIL HCL 525 434 13 26
HYDROCODONE-ACETAMINOPHEN 511 380 S3 14 4
LACTULOSE 501 202 15 111
POTASSIUM CHLORIDE 474 360 16 14
FLUOXETINE HCL 450 98 17 83
OMEPRAZOLE 447 238 18 7
CARBAMAZEPINE 398 60 19 217
ALENDRONATE SODIUM 385 141 20 23
TAMSULOSIN HCL 378 206 21 29
SERTRALINE HCL 375 192 22 27
LEVETIRACETAM 352 108 23 103
ALBUTEROL SULFATE 351 266 24 134
DIVALPROEX SODIUM 342 204 25 100
CYMBALTA 340 286 26 44
CARBIDOPA-LEVODOPA 340 329 26 113
FAMOTIDINE 335 174 28 75
BUMETANIDE 326 306 29 203
METFORMIN HCL 321 149 30 8
OLANZAPINE 320 104 31 137
ROPINIROLE HCL 297 285 32 115
GABAPENTIN 292 138 33 13
JANUVIA 280 239 34 48
CRESTOR 275 65 35 20
NEXIUM 271 66 36 19
IPRATROPIUM-ALBUTEROL 269 215 37 150
NAPROXEN 256 102 38 80
TOPIRAMATE 255 84 39 206
BENZTROPINE MESYLATE 249 107 R 40 191
PATANOL 246 136 41 237
LANTUS 242 196 42 45
DOXYCYCLINE HYCLATE 232 37 43 123
ZOLPIDEM TARTRATE 226 158 44 17
DIVALPROEX SODIUM ER 219 32 45 185
LATANOPROST 213 137 46 197
RANITIDINE HCL 204 77 47 56
FLUTICASONE PROPIONATE 203 45 48 32
ABILIFY 202 70 49 172
METOCLOPRAMIDE HCL 191 68 50 116
CARVEDILOL 190 130 51 21
WARFARIN SODIUM 188 140 52 22
MELOXICAM 180 104 53 31
NATEGLINIDE 178 156 54 274
DIOVAN 173 129 55 35
QUETIAPINE FUMARATE 172 95 56 66
LIPITOR 170 45 57 78
NOVOLOG 169 140 58 114
FENOFIBRATE 169 123 58 65
SPIRIVA 166 163 60 79
PHENYTOIN SODIUM EXTENDED 161 13 61 128
CITALOPRAM HBR 159 22 62 24
EXELON 158 141 63 106
KLOR-CON M10 157 135 64 118
METOPROLOL SUCCINATE 157 53 64 11
BUSPIRONE HCL 156 80 66 148
AMLODIPINE BESYLATE-BENAZEPRIL 152 80 67 67
KLOR-CON M20 151 130 68 90
HYDROCHLOROTHIAZIDE 149 87 69 15
POLYETHYLENE GLYCOL 3350 149 40 69 93
BACLOFEN 148 55 71 121
CLOPIDOGREL 148 109 71 30
ALLOPURINOL 143 131 73 37
SINGULAIR 143 26 73 85
LOSARTAN POTASSIUM 143 106 73 18
PRAVASTATIN SODIUM 140 83 76 12
DORZOLAMIDE-TIMOLOL 139 84 77 421
ESCITALOPRAM OXALATE 139 74 77 62
CLONIDINE HCL 136 83 79 39
LEVOFLOXACIN 135 110 80 57
PLAVIX 131 105 81 40
PREDNISONE 129 98 82 42
BRIMONIDINE TARTRATE 125 96 83 338
TRAVATAN Z 124 104 84 239
TRICOR 121 33 85 91
OXYBUTYNIN CHLORIDE ER 118 15 86 132
GLYCOPYRROLATE 117 47 87 436
VENLAFAXINE HCL ER 116 73 88 120
DILANTIN 114 12 89 326
LAMOTRIGINE 113 31 90 257
ZETIA 111 17 91 81
CHLORHEXIDINE GLUCONATE 108 31 92 289
RAMIPRIL 107 57 93 73
OXYBUTYNIN CHLORIDE 106 48 94 124
ENALAPRIL MALEATE 100 44 95 49
CARBAMAZEPINE XR 100 0 95 485
GEMFIBROZIL 98 49 97 98
CIPROFLOXACIN HCL 97 70 98 47
SULFAMETHOXAZOLE-TRIMETHOPRIM 96 80 99 88
DOXAZOSIN MESYLATE 94 56 100 94
LIDODERM 94 84 100 105
MONTELUKAST SODIUM 94 21 100 153
ISOSORBIDE MONONITRATE ER 93 68 103 51
SPIRONOLACTONE 90 47 104 70
OXCARBAZEPINE 89 15 105 342
LITHIUM CARBONATE 89 0 105 426
ACTOS 89 34 105 108
GENERLAC 89 32 105 318
PROMETHAZINE HCL 86 37 R 109 96
MUPIROCIN 86 57 109 184
AMITIZA 86 54 109 296
IPRATROPIUM BROMIDE 85 62 112 188
PROPRANOLOL HCL 84 27 113 164
VENLAFAXINE HCL 83 56 114 246
ATENOLOL 82 58 115 25
ADVAIR DISKUS 82 52 115 60
NYSTATIN 82 53 115 178
TIZANIDINE HCL 82 54 115 133
HUMALOG 79 72 119 166
NOVOLOG FLEXPEN 73 66 120 171
VESICARE 73 0 120 154
KETOCONAZOLE 73 12 120 270
VALPROIC ACID 73 59 120 278
CLONIDINE 70 45 124 247
GLYBURIDE 70 45 R 124 58
PHENYTOIN 69 36 126 302
SEROQUEL 69 36 126 143
RESTASIS 68 32 128 352
TRILIPIX 68 0 128 160
DETROL LA 68 20 128 192
HEPARIN SODIUM 67 36 131 458
DILTIAZEM ER 67 34 131 182
ZIPRASIDONE HCL 66 15 133 358
LEVEMIR FLEXPEN 65 65 134 156
CEPHALEXIN 65 36 134 119
LOSARTAN-HYDROCHLOROTHIAZIDE 64 37 136 46
NITROGLYCERIN PATCH 64 45 136 183
MICROGESTIN FE 63 0 10 138 542
PANTOPRAZOLE SODIUM 63 22 138 33
NITROFURANTOIN MONO-MACRO 62 50 140 162
ZYPREXA 61 0 141 399
SANTYL 59 49 142 210
CYPROHEPTADINE HCL 57 32 R 143 472
NOVOLIN R 57 38 143 109
CLOBETASOL PROPIONATE 57 32 143 298
LYRICA 56 43 146 69
NASONEX 55 18 147 168
AZITHROMYCIN 55 29 147 38
CYCLOBENZAPRINE HCL 55 37 R 147 68
CEFDINIR 54 46 150 194
DIGOXIN 54 54 150 55
TRIAMTERENE-HCTZ 53 41 152 63
SEROQUEL XR 53 13 152 271
PATADAY 50 12 154 261
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 9, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.